Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Metabolix readies IPO ...

July 24, 2006 | A version of this story appeared in Volume 84, Issue 30

The industrial biotechnology firm Metabolix has filed with the Securities & Exchange Commission for an initial public offering that it hopes will raise as much as $86.3 million. Archer Daniels Midland has agreed to purchase $7.5 million in Metabolix common stock. ADM and Metabolix have plans to build a plant that will make polyhydroalkanoate plastics via fermentation. Metabolix is also working on a biorefinery system to produce PHA and biomass feedstock for ethanol. Metabolix reported revenue of about $2.8 million in 2005 and a net loss of about $7.6 million.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.